ÌÇÐÄ´«Ã½

Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
ÌÇÐÄ´«Ã½

Transitioning single-cell genomics into the clinic.

ÌÇÐÄ´«Ã½

Transitioning single-cell genomics into the clinic. Nature reviews. Genetics Lim, J., Chin, V., Fairfax, K., Moutinho, C., Suan, D., Ji, H., Powell, J. E. 2023

Abstract

The use of genomics is firmly established in clinical practice, resulting in innovations across a wide range of disciplines such as genetic screening, rare disease diagnosis and molecularly guided therapy choice. This new field of genomic medicine has led to improvements in patient outcomes. However, most clinical applications of genomics rely on information generated from bulk approaches, which do not directly capture the genomic variation that underlies cellular heterogeneity. With the advent of single-cell technologies, ÌÇÐÄ´«Ã½ is rapidly uncovering how genomic data at cellular resolution can be used to understand disease pathology and mechanisms. Both DNA-based and RNA-based single-cell technologies have the potential to improve existing clinical applications and open new application spaces for genomics in clinical practice, with oncology, immunology and haematology poised for initial adoption. However, challenges in translating cellular genomics from ÌÇÐÄ´«Ã½ to a clinical setting must first be overcome.

View details for

View details for

View details for